Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
2 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Lenalidomide treatment of isolated central nervous system relapse in acute
lymphoblastic leukemia after HSCT and CAR-T cell therapy.
Acta Haematol. 2024 Feb 15. doi: 10.1159/000537719.
PubMed
Abstract available
Prevalence, risk factors, and prognostic value of anxiety and depression in acute
myeloid leukemia.
Acta Haematol. 2024 Feb 11. doi: 10.1159/000536457.
PubMed
Abstract available
Targetable genetic abnormalities in patients with acute myeloblastic leukemia
across age groups.
Am J Hematol. 2024 Feb 15. doi: 10.1002/ajh.27236.
PubMed
Abstract available
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma
accounting for small molecule inhibitors: A real-world cohort analysis.
Am J Hematol. 2024 Feb 15. doi: 10.1002/ajh.27241.
PubMed
Abstract available
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in
chemotherapy-ineligible untreated acute myeloid leukemia.
Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27246.
PubMed
Abstract available
Venetoclax infectious risk score to identify patients with chronic lymphocytic
leukemia at high infectious risk during venetoclax treatment: A multicenter
SEIFEM study.
Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27247.
PubMed
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline
treatment in patients 75 years and older with acute myeloid leukemia: Real-world
data from eight US academic centers.
Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27231.
PubMed
Abstract available
The indirect effects of CMV reactivation on patients following allogeneic
hematopoietic stem cell transplantation: an evidence mapping.
Ann Hematol. 2024;103:917-933.
PubMed
Abstract available
Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and
infection risk at a single center.
Ann Hematol. 2024;103:1031-1033.
PubMed
Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking
inflammatory bowel disease, successfully treated with acalabrutinib.
Ann Hematol. 2024;103:1021-1023.
PubMed
How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in
children.
Blood. 2024 Feb 16:blood.2023023155. doi: 10.1182/blood.2023023155.
PubMed
Abstract available
A 3-year-old with chronic myeloid leukemia.
Blood. 2024;143:651.
PubMed
Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin
inhibitors.
Blood. 2024;143:619-630.
PubMed
Abstract available
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and
molecular leukemogenic features.
Blood. 2023;142:1752-1756.
PubMed
Abstract available
Validation of the transplant conditioning intensity (TCI) index for allogeneic
hematopoietic cell transplantation.
Bone Marrow Transplant. 2024;59:217-223.
PubMed
Abstract available
A comparison of long-term outcomes by donor type in the era of
post-transplantation cyclophosphamide for aggressive adult T-cell
leukemia/lymphoma.
Bone Marrow Transplant. 2024 Feb 14. doi: 10.1038/s41409-024-02231.
PubMed
Ivosidenib significantly reduces triazole levels in patients with acute myeloid
leukemia and myelodysplastic syndrome.
Cancer. 2024 Feb 10. doi: 10.1002/cncr.35251.
PubMed
Abstract available
STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity
of Vdelta2(+) T cells in acute myeloid leukemia.
Cancer Lett. 2024 Feb 13:216730. doi: 10.1016/j.canlet.2024.216730.
PubMed
Abstract available
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1
Inhibition by Triggering Transcription-Replication Conflicts.
Cancer Res. 2024;84:577-597.
PubMed
Abstract available
Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC-MRD
and treatment guidance for elderly patients.
Eur J Haematol. 2024 Feb 11. doi: 10.1111/ejh.14187.
PubMed
Abstract available
Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell
lines of myeloid leukemia associated with Down syndrome.
Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
PubMed
Abstract available
Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
Exp Hematol. 2024;130:104130.
PubMed
Abstract available
Dysregulated hemostasis in acute promyelocytic leukemia.
Int J Hematol. 2024 Feb 11. doi: 10.1007/s12185-024-03708.
PubMed
Abstract available
Phase separation promotes a highly active oligomeric scaffold of the MLL1 core
complex for regulation of histone H3K4 methylation.
J Biol Chem. 2023;299:105204.
PubMed
Abstract available
Outcomes of haploidentical hematopoietic stem cell transplantation with 'Beijing
protocol' in pediatric myeloid neoplasms post cytotoxic therapy: a case series
study.
Leuk Lymphoma. 2023 Dec 3:1-6. doi: 10.1080/10428194.2023.2281276.
PubMed
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1
upregulation.
Leuk Lymphoma. 2023;64:1662-1672.
PubMed
Abstract available
Systematic review and meta-analysis evaluating clinical outcomes in adult acute
myeloid leukemia patients with central nervous system involvement.
Leuk Res. 2024;137:107452.
PubMed
Abstract available
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute
Lymphoblastic Leukemia: A Children's Oncology Group Report.
Leukemia. 2024 Feb 15. doi: 10.1038/s41375-024-02166.
PubMed
Abstract available
Correction: Anti-inflammatory effects of cold atmospheric plasma irradiation on
the THP-1 human acute monocytic leukemia cell line.
PLoS One. 2024;19:e0299329.
PubMed
Abstract available
Organomegalies as a predictive indicator of leukemia cutis in patients with acute
myeloid leukemia.
PLoS One. 2024;19:e0297805.
PubMed
Abstract available
Thank you for your interest in scientific medicine.